Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cormedix Inc (CRMD)

Cormedix Inc (CRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 651,671
  • Shares Outstanding, K 60,677
  • Annual Sales, $ 0 K
  • Annual Income, $ -46,340 K
  • EBIT $ -51 M
  • EBITDA $ -51 M
  • 60-Month Beta 1.58
  • Price/Sales 50.67
  • Price/Cash Flow N/A
  • Price/Book 11.27

Options Overview Details

View History
  • Implied Volatility 69.53% ( -6.00%)
  • Historical Volatility 95.45%
  • IV Percentile 25%
  • IV Rank 23.59%
  • IV High 180.81% on 07/08/24
  • IV Low 35.17% on 10/03/24
  • Put/Call Vol Ratio 0.34
  • Today's Volume 700
  • Volume Avg (30-Day) 3,037
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 31,841
  • Open Int (30-Day) 41,962

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.06
  • Number of Estimates 1
  • High Estimate 0.06
  • Low Estimate 0.06
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +123.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.40 +14.26%
on 11/04/24
13.85 -22.45%
on 10/29/24
-0.27 (-2.45%)
since 10/18/24
3-Month
4.87 +120.53%
on 08/22/24
13.85 -22.45%
on 10/29/24
+5.72 (+113.94%)
since 08/20/24
52-Week
2.89 +271.63%
on 02/08/24
13.85 -22.45%
on 10/29/24
+6.96 (+184.13%)
since 11/20/23

Most Recent Stories

More News
Best Momentum Stocks to Buy for November 8th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 8:CorMedix Inc. CRMD: This biopharmaceutical company has a Zacks Rank #1 and witnessed...

SPPJY : 2.8280 (+1.00%)
CRMD : 10.74 (-2.98%)
FFIC : 17.07 (-0.58%)
New Strong Buy Stocks for November 8th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Sappi Limited SPPJY: This wood fiber-based renewable resources company has seen the Zacks Consensus Estimate for its current year...

NTGR : 24.10 (-0.29%)
SPPJY : 2.8280 (+1.00%)
AACAY : 3.9800 (+4.79%)
CRMD : 10.74 (-2.98%)
FFIC : 17.07 (-0.58%)
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

CRMD : 10.74 (-2.98%)
CorMedix (CRMD) Q3 2024 Earnings Call Transcript

CRMD earnings call for the period ending September 30, 2024.

CRMD : 10.74 (-2.98%)
CorMedix: Q3 Earnings Snapshot

CorMedix: Q3 Earnings Snapshot

CRMD : 10.74 (-2.98%)
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

CRMD : 10.74 (-2.98%)
CorMedix Inc. Announces New Data at ASN Kidney Week 2024

CRMD : 10.74 (-2.98%)
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024

CRMD : 10.74 (-2.98%)
CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator

CRMD : 10.74 (-2.98%)
CorMedix (CRMD) Q2 2024 Earnings Call Transcript

CRMD earnings call for the period ending June 30, 2024.

CRMD : 10.74 (-2.98%)

Business Summary

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath (TM), a novel, antibacterial and antifungal solution designed...

See More

Key Turning Points

3rd Resistance Point 12.04
2nd Resistance Point 11.73
1st Resistance Point 11.23
Last Price 10.74
1st Support Level 10.42
2nd Support Level 10.11
3rd Support Level 9.61

See More

52-Week High 13.85
Last Price 10.74
Fibonacci 61.8% 9.66
Fibonacci 50% 8.37
Fibonacci 38.2% 7.08
52-Week Low 2.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar